- Application for Temporary Registration of Pharmacist with Pharmacy Board of Malaysia
- List of Training Premises for Provisionally Registered Pharmacist (PRP)
- Psoriasis Medication Therapy Adherence Clinic (MTAC) Protocol Third Edition
- Obstetrics & Gynaecology Ward Pharmacy Services Protocol
- Thalassaemia Medication Therapy Adherence Clinic (TMTAC) Protocol
You are here
Formulari Ubat KKM (FUKKM)
| # | Generic Name | MDC | Category | Indications | Pres. Restrictions | Dosage |
|---|---|---|---|---|---|---|
| 1 | Atomoxetine HCl 10mg Capsule | N06BA09-110-C10-01-XXX | A* | Attention deficit hyperactivity disorder (ADHD) in children 6 years and older who do not respond to methylphenidate or who have intolerable effects or have tics. Diagnosis should be made according to DSM IV criteria or the guidelines in ICD-10 | None | CHILD and ADOLESCENTS up to 70 kg: Initially 0.5 mg/kg/day for at least 7 days, then increased according to response. Maintenance: 1.2 mg/kg/day. ADULTS and ADOLESCENTS more than 70 kg: Initially 40 mg/day for at least 7 days then increased according to response. Maintenance: 80 mg/day. Max 100 mg/ day |
| 2 | Atomoxetine HCl 18mg Capsule | N06BA09-110-C10-02-XXX | A* | Attention deficit hyperactivity disorder (ADHD) in children 6 years and older who do not respond to methylphenidate or who have intolerable effects or have tics. Diagnosis should be made according to DSM IV criteria or the guidelines in ICD-10 | None | CHILD and ADOLESCENTS up to 70 kg: Initially 0.5 mg/kg/day for at least 7 days, then increased according to response. Maintenance: 1.2 mg/kg/day. ADULTS and ADOLESCENTS more than 70 kg: Initially 40 mg/day for at least 7 days then increased according to response. Maintenance: 80 mg/day. Max 100 mg/ day |
| 3 | Atomoxetine HCl 25mg Capsule | N06BA09-110-C10-03-XXX | A* | Attention deficit hyperactivity disorder (ADHD) in children 6 years and older who do not respond to methylphenidate or who have intolerable effects or have tics. Diagnosis should be made according to DSM IV criteria or the guidelines in ICD-10 | None | CHILD and ADOLESCENTS up to 70 kg: Initially 0.5 mg/kg/day for at least 7 days, then increased according to response. Maintenance: 1.2 mg/kg/day. ADULTS and ADOLESCENTS more than 70 kg: Initially 40 mg/day for at least 7 days then increased according to response. Maintenance: 80 mg/day. Max 100 mg/ day |
| 4 | Atomoxetine HCl 40mg Capsule | N06BA09-110-C10-04-XXX | A* | Attention deficit hyperactivity disorder (ADHD) in children 6 years and older who do not respond to methylphenidate or who have intolerable effects or have tics. Diagnosis should be made according to DSM IV criteria or the guidelines in ICD-10 | None | CHILD and ADOLESCENTS up to 70 kg: Initially 0.5 mg/kg/day for at least 7 days, then increased according to response. Maintenance: 1.2 mg/kg/day. ADULTS and ADOLESCENTS more than 70 kg: Initially 40 mg/day for at least 7 days then increased according to response. Maintenance: 80 mg/day. Max 100 mg/ day |
| 5 | Atomoxetine HCl 60mg Capsule | N06BA09-110-C10-05-XXX | A* | Attention deficit hyperactivity disorder (ADHD) in children 6 years and older who do not respond to methylphenidate or who have intolerable effects or have tics. Diagnosis should be made according to DSM IV criteria or the guidelines in ICD-10 | None | CHILD and ADOLESCENTS up to 70 kg: Initially 0.5 mg/kg/day for at least 7 days, then increased according to response. Maintenance: 1.2 mg/kg/day. ADULTS and ADOLESCENTS more than 70 kg: Initially 40 mg/day for at least 7 days then increased according to response. Maintenance: 80 mg/day. Max 100 mg/ day |
| 6 | Methylphenidate HCl 10 mg Tablet | N06BA04110T1001XX | A | Attention deficit hyperactivity disorder (ADHD) | CHILD over 6 years, initially 5 mg 1 - 2 times daily, increased if necessary at weekly intervals by 5 - 10 mg daily to maximum of 60 mg daily in divided doses; discontinue if no response after 1 month, also suspend periodically to assess child's condition (usually finally discontinued during or after puberty) | |
| 7 | Methylphenidate HCl 18 mg Extended-release Tablet | N06BA04110T5002XX | A* | Attention deficit hyperactivity disorder (ADHD) | CHILD over 6 years: Individualize dosage, to be taken once daily in the morning. Dose may be adjusted in increments to a maximum of 54 mg/day, at weekly interval. Patient new to methylphenidate: starting dose 18 mg once daily; adults 18mg or 36mg once daily. Patient currently using methylphenidate: 18 - 36 mg. Maximum 54 mg/day. Discontinue if no response after 1 month | |
| 8 | Methylphenidate HCl 20 mg LA Capsule | N06BA04110C2003XX | A* | Attention deficit hyperactivity disorder (ADHD) | 20 mg once daily to be taken in the morning. Dosage be adjusted in increments to a maximum of 60 mg/day | |
| 9 | Methylphenidate HCl 36 mg Extended-release Tablet | N06BA04110T5003XX | A* | Attention deficit hyperactivity disorder (ADHD) | CHILD over 6 years: Individualize dosage, to be taken once daily in the morning. Dose may be adjusted in increments to a maximum of 54 mg/day, at weekly interval. Patient new to methylphenidate: starting dose 18 mg once daily; adults 18mg or 36mg once daily. Patient currently using methylphenidate: 18 - 36 mg. Maximum 54 mg/day. Discontinue if no response after 1 month | |
| 10 | Methylphenidate HCl 40mg LA Capsule | N06BA04110C2002XX | A* | Attention deficit hyperactivity disorder (ADHD) | 20 mg once daily to be taken in the morning. Dosage be adjusted in increments to a maximum of 60 mg/day |